Burden of Serious Fungal Infections in the Czech Republic Ales Chrdle a, Nada Mallatova b, David W Denning c Objectives We have estimated the number of.

Slides:



Advertisements
Similar presentations
Health Statistics and Informatics Global Burden of Disease 2004 Update: Selected figures and tables Health Statistics and Informatics Department.
Advertisements

GARD Global Alliance against Chronic Respiratory Diseases WHO J Bousquet, R Dahl, N Khaltaev, HJ Bekedam.
Chronic pulmonary aspergillosis
The burden of invasive and serious fungal disease in the UK Denning DW 1, Pegorie M 2, Welfare W 2,3 24th European Congress of Clinical Microbiology and.
Trends in fungal disease in the UK Theresa Lamagni Healthcare-Associated Infection & Antimicrobial Resistance Department HPA Centre for Infections.
Airborne fungi infections Dr David W. Denning FRCP FRCPath Scientific Advisor to the Fungal Research Trust Clinician, Wythenshawe Hospital Head, Antifungal.
OPPORTUNISTIC FUNGAL INFECTIONS
Discussion & Limitations Whereas the number of candidaemia cases and AIDS defining fungal infection in HIV patients are systematically surveyed, most fungal.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE Major Killer disease in the world Chronic progressive disease of the lung caused by inhalation of toxic substances.
Burden of Serious Fungal Infections in Argentina Roxana G. Vitale, David W Denning Hospital Ramos Mejía and CONICET; Buenos Aires, Argentina; Manchester.
U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.
Conclusion Estimating the burden of fungal disease in Vietnam ResultsBackground Methods The prevalence of fungal infections in Vietnam is poorly described,
1 Institute of Epidemiology and Infectious Diseases Research Activities The L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases Svetlana.
Surveillance report Annual Epidemiological Report on communicable diseases in Europe ECDC Surveillance Unit European Centre for Disease Prevention and.
World Health Organization Department of Chronic Diseases and Health Promotion World Health Organization Gojka Roglic THE GLOBAL BURDEN OF DIABETES AND.
Chapter 8 - Focus Chapter : Chronic obstructive pulmonary disease among people aged 55 years and over.
10 year Roadmap by 2025 David W. Denning President GAFFI The University of Manchester.
[ Routine BCG vaccination to newborns- Future challenges Prof. Fahad Abdullah Al Zamil Professor and Consultant, Pediatric Infectious Diseases Head of.
Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases National Heart, Lung, and Blood Institute February, 2012.
HIV/AIDS Epidemiology Update February 2009 Dr Nigel Dickson Director, AIDS Epidemiology Group Department of Preventive and Social Medicine University of.
Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.
Introduction Background : Asthma is a common chronic airway disorder characterized by periods of reversible airflow obstruction known as asthma attack.
Estimating the Burden of Serious Fungal Diseases in Thailand Methee Chayakulkeeree 1, David W. Denning 2* 1 Division of Infectious Diseases and Tropical.
South Service Planning Area (SPA 6) and King-Drew Medical Center Health Needs Planning Data 2004 Compiled by LAC DHS Office of Planning, 2004.
A-50 Table 7.1: U.S. Population Trends and Projections (1) by Age, 1980 – 2050 Source: U.S. Department of Commerce, Bureau of the Census. U.S. Interim.
Module 2 - Epidemiology of Tuberculosis
Opportunistic Pathogens –Aspergillus species. Aspergillosis is an infection caused by Aspergillus, a common mold that lives indoors and outdoors. Most.
Focus Area 24 Respiratory Diseases Progress Review June 29, 2004.
* rate for adult females only The burden of serious fungal diseases in Madagascar Rivo Andry Rakotoarivelo, 1 Voahangy Rasolofo Razanamparany, 2 Jocelyn.
Maria N. Gamaletsou 1,2, David Denning 1, and Nikolaos V. Sipsas 2 1 The National Aspergillosis Centre, University Hospital of South Manchester and The.
THE BURDEN OF SERIOUS FUNGAL INFECTIONS IN VENEZUELA Maribel Dolande 1, María Mercedes Panizo 1, Giuseppe Ferrara 1, Víctor Alarcón 1, Nataly García 1,
OBJECTIVEMETHODSRESULTS BURDEN OF SERIOUS FUNGAL INFECTIONS IN SERBIA Valentina Arsic Arsenijevic 1, Sandra Sipetic Grujicic 2, Marina Pekmezovic 1, David.
The burden of serious fungal infections in Portugal Raquel Sabino 1, Cristina Verissímo C 1, Célia Pais 2, David W. Denning 3 1 Nacional Institute of Health.
SUDEP Amer Aboukasm, MD, FACP. S UDDEN U nexpected D eath in E pilepsy P atients.
Similarities and differences between developing countries and Australia Chapter 8.2.
* rate for adult females only An estimation of burden of serious fungal infections in France Jean-Pierre Gangneux 1, Marie-Elisabeth Bougnoux 2, Cendrine.
Respiratory System Disorders. Infectious Diseases  Caused by viruses or bacteria  Bronchitis  Pneumonia  Tuberculosis (TB)  Common Cold.
COPD Local Burden. Population Prevalence of GOLD Stage I and Stage II & Doctor Diagnosed COPD in Manila, Philippines Source: BOLD Study, 2007;Dantes R.
A-52 Table 7.1: U.S. Population Trends and Projections by Age, 1980 – 2060 (1) Source: U.S. Department of Commerce, Bureau of the Census. Projections.
Candidaemia in Critically Ill Patients Dr Bunny Saberwal, Mrs Rakhee Patel, Dr Seng Zhi Quan and Dr A. Gonzalez ICE 2.
Correspondence: Bustamante, B: Campos PE: Denning DW:
Fungal infection accounts for significant rates of morbidity and mortality; however, there is paucity of systematic data on the incidence and prevalence.
The burden of serious fungal diseases in Japan Koichi Izumikawa 1, Masato Tashiro 1, Takahiro Takazono 1, Shintaro Kurihara 1, Tomomi Saijo 2, Kazuko Yamamoto.
1 Body-Mass Index and Mortality in Korean Men and Women Sun Ha Jee, Ph.D., Jae Woong Sull, Ph.D., Jung yong Park, Ph.D., Sang-Yi Lee, M.D. From the Department.
Fungal diseases in the UK
Worldwide availability and pricing of antifungal drugs
Estimated burden of fungal infections in Italy
BASIC HEALTH INDICATORS CHANGES AFTER NATURAL DISASTER
Estimating serious fungal disease burden in the Philippines
Number of infections per underlying disorder per year
Emergence of Clinically Relevant
Universidad Militar Nueva Granada, School of Medicine
Number of infections per underlying disorder per year
8th Advances Against Aspergillosis international conference
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome  J. Guinea, M. Torres-Narbona, P.
How common are fungal diseases?
Incidence or Prevalence, per 100,000 Burden, no. of cases per year*
M. Inghammar, G. Engström, G. Kahlmeter, B. Ljungberg, C. -G
8th Advances Against Aspergillosis international conference
The changing epidemiology of severe infections in the ICU
Candida glabrata fungaemia in intensive care units
Cryptococcosis: Epidemiology of cryptococcal disease
Clinical Microbiology and Infection
Epidemiology of invasive fungal infections due to Aspergillus spp
Cryptococcosis: Epidemiology of cryptococcal disease
Forest plot showing the number of adults (at the top) and children (lower down) who were admitted to hospital after treatment in the emergency department.
3-year survival of lung cancer patients in the general population and in those with a prior diagnosis of chronic obstructive pulmonary disease (COPD).
Schematic diagram of the shared subgroups between asthma and chronic obstructive pulmonary disease (COPD). Schematic diagram of the shared subgroups between.
Lesions that represent potential mimickers of cyst-related primary lung malignancies. a) Irregular thick-walled cystic airspace in a 74-year-old male as.
Classification of allergic fungal disease in asthma.
Presentation transcript:

Burden of Serious Fungal Infections in the Czech Republic Ales Chrdle a, Nada Mallatova b, David W Denning c Objectives We have estimated the number of serious fungal infections in order to define the burden of these diseases in the Czech Republic. References 1 Hamal, P., Kocmanová I., Jedličková, A., et al. Epidemiological analysis of candidemia in Czech tertiary care hospitals in J Chemother 2007, vol. 19, suppl. 3, p (Abstracts of the 3rd Trends in Medical Mycology, October 2007, Torino, Italy) 2 Kocmanová I., Drgoňa L., Ráčil Z. et al. Invasive candidiasis in selected heamatology departments in the Czech Republic and Slovakia – microbiological results of the CAN CELL project. Klin Mikrobiol Inf Lek 2011;17(1):4–9. 3 Nohýnková E. Toxoplasma, Pneumocystis, Trichomonas, Leptospira – what do they have in common? Seminar of SEM ČLS JEP and ČPS convened at the 105th anniversary of birth and 40th anniversary of death of prof Otto Jírovec (coordinator: RNDr. Libor Mikeš, PhD)., Lékařský dům, 3 April 2012, Prague, Czech Republic 4 Sedlacek P.,Chrenkova V., Mudry P. et al. Probable/proven invasive aspergillosis in children with malignancy registered in database FIND, Study on behalf of the Czech Leukemia Study Group for life CELL. Mycoses 2013, Blackwell Verlag GmbH, 56 (Suppl. 3), 55–167 5 Weinbergerova B., Racil Z., Kocmanova I. et al. Invasive aspergillosis in patients with hematological malignancies in Czech and Slovak Republics: fungal infection database (FIND) analysis (2001–2011) – an update. Mycoses 2013 Blackwell Verlag GmbH, 56 (Suppl. 3), 55–167 6 Czech Health Statistics Yearbook - ISSN ISBN (accessed 8 December 2013) 7 UZIS Health Statistics 2011, p ISSN ( ). ISBN (accessed 8 December 2013) 8 TB and repiratory disease Report ISSN: , ( ). (accessed 8 December 2013) 9 (accessed 8 December 2013) 10 (accessed 8 December 2013) 11 Czech Transplant Coordinating Centre (accessed 8 December 2013) 12 (accessed 8 December 2013) 13 Foxman B., Muraglia R., Dietz JP. et al. Prevalence of Recurrent Vulvovaginal Candidiasis in 5 European Countries and the United States: Results From an Internet Panel Survey.Journal of Lower Genital Tract Disease, Volume 17, Number 3, 2013, Denning D., Pleuvry A., Cole DC. Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults. Medical Mycology May 2013, 51, 361– Arendrup MC. Epidemiology of invasive candidiasis. Curr Opin Crit Care Oct;16(5): Cancer registry, UZIS, p. 92, ISSN X, ISBN (accessed 8 December 2013) 17 DRG registry UZIS.CZ ISBN: (accessed 8 December 2013) 18 (accessed 8 December 2013). a Ceske Budejovice Hospital, Department of Infectious Diseases, Czech Republic b Laboratory of Parasitology and Mycology, Ceske Budejovice Hospital, Czech Republic c The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK, in assocation with the LIFE program at Methods All published epidemiology papers reporting Czech fungal infection rates were identified 1-5. Where no data existed, we used specific populations at risk and fungal infection frequencies in those populations to estimate national incidence or prevalence, depending on the condition. Population statistics were obtained from the 2011 Census data 6, number of critical beds 7 and numbers of chronic obstructive pulmonary disease (COPD) and asthma cases in 2012 were derived from the Institute of Health Information and Statistics 8. The 2012 HIV/AIDS 9,10 and tuberculosis cases 8 were obtained from the State Institute of Public Health, transplant cases from the Czech Transplant Coordination Centre 11, and cystic fibrosis cases from the European Cystic Fibrosis Society 12. Results 85% of the 10.5 M population are adults, 15% are children below 14 years. There are 4.6 M women over 15 years of age, of whom 45% are over 50 years of age. Fungal disease burden estimates are: 152,840 Czech women get recurrent vaginal thrush 13. Of the 552 cases of tuberculosis in 2012, 23 new cases of chronic pulmonary aspergillosis (CPA) the 5-year period prevalence is 73 cases are estimated. As total CPA cases in COPD are more frequent, 365 total CPA cases are estimated. Reported adult asthma prevalence is ~2% and assuming 2.5% of asthmatics have allergic bronchopulmonary aspergillosis (ABPA), 5,216 patients with ABPA 14 are likely and 6,842 more with severe asthma with fungal sensitisation (SAFS). Of the 1,619 estimated HIV positive patients the annual incidence of Pneumocystis pneumonia is 0.13/100,000 consistent with 13 cases 9. The Pneumocystis pneumonia burden in immunosuppressed non-HIV population is presumed to be three to four times higher 3. In HIV infection, oesophageal candidiasis is estimated to occur in 131 cases 9,10. The rate of candidemia is estimated to 5/100,000 population 15 consistent with 525 cases, along with 79 cases of Candida peritonitis among more than 70,000 abdominal surgeries a year 7. Invasive aspergillosis in immuno- compromised patients is estimated at 343 patients annually 4,5 including 206 cases in critical care 16,17, many with COPD. There have been 637 cases of tinea capitis and/or corporis notified, but may be underrepresented, as this not notifiable disease 18. Conclusion Using local data and literature estimates of the incidence or prevalence of fungal infections, nearly 170,000 (1.7%) people in the Czech Republic suffer from severe fungal infection each year. These figures are dominated by recurrent vaginitis, followed by allergic respiratory conditions. Substantial uncertainty surrounds these estimates except for invasive aspergillosis in haematology 4,5 and candidaemia in critical care 1,2, where population based surveillance studies have been recently presented. Therefore, epidemiological studies are urgently required to validate or modify these estimates. Infection Number of infections per underlying disorder per year Total burden Rate /100K None HIV/ AIDS Respir. Cancer /Tx ICU Oesophageal candidiasis -131?? Candidaemia Candida peritonitis Recurrent vaginal candidiasis (4x/year) 152, ,908* ABPA --5, SAFS --6, Chronic pulmonary aspergillosis Invasive aspergillosis Mucormycosis Cryptococcal meningitis -<5--- Pneumocystis pneumonia -13? Tinea capitis/corporis Total burden estimated 153, , ,030 * Rate per 100,000 women